Pills and sprays to replace Covid jabs: Vaccine tsar Kate Bingham says needles will be phased out in battle against mutating virus - and reveals she broke Dry January with glass of wine when she heard UK-made Novavax passed trials with 90% success rate
Kate Bingham revealed that she was part of Novavax trial that was found to defeat Covid in 9 out of 10 cases
US biotech firm announced its vaccine had successfully completed Phase Three clinical trials in UK
Under a deal with the UK government, 60million doses of the vaccine will be produced on Teesside for UK use
The vaccine still requires final approval from the UK s Medicines and Healthcare products Regulatory Agency
Updated Jan 28, 2021 | 18:17 IST
Even marginal changes in the rate of transmissibility can have outsize impacts concerning the total number of cases and casualties. A pharmacist administers a dose of the Oxford/AstraZeneca vaccine to an individual at a coronavirus vaccination clinic held at Junction Pharmacy in Brixton, London, Thursday, Jan. 28, 2021. | Photo Credit: AP
Key Highlights
For the most part, subtle changes in a virus genetic code are unimportant and harmless but as these mutations accumulate, the probability of a virus becoming more transmissible or lethal gradually increases
Researchers have specifically sounded warnings over the UK and South Africa variants because they appear to spread much faster than the original strain
US biotech firm Novavax announced its vaccine had successfully completed Phase Three clinical trials in UK
Under a deal with the UK government, 60million doses of the vaccine will be produced on Teesside for UK use
The vaccine still requires final approval from the UK s Medicines and Healthcare products Regulatory Agency
The firm Novavax last night said that the trials had shown its coronavirus vaccine was 89.3 per cent effective
This trial is the first to be completed since the emergence of the new variant of the Covid-19 disease in Kent